<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02667184</url>
  </required_header>
  <id_info>
    <org_study_id>1507E75043</org_study_id>
    <nct_id>NCT02667184</nct_id>
  </id_info>
  <brief_title>The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects</brief_title>
  <official_title>The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Health Human Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine subjective gastrointestinal tolerance response and
      differences in breath hydrogen response following the consumption of different types of low
      FODMAP oral nutrition supplements. This randomized, crossover study requires participants to
      arrive to the lab 12 hours fasted, consume an oral liquid supplement and complete
      gastrointestinal tolerance questionnaires as well as produce samples for breath hydrogen
      analysis at various time points over a 4 hour time period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized, crossover study requires participants to arrive to the lab 12 hours fasted,
      consume an oral liquid supplement and complete gastrointestinal tolerance questionnaires as
      well as produce samples for breath hydrogen and methane analysis at various time points over
      a 4 hour time period. Subjects will also be asked to rate gastrointestinal symptoms via a
      questionnaire at various time points throughout the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breath hydrogen response</measure>
    <time_frame>baseline</time_frame>
    <description>At baseline, subjects will be asked to exhale a full breath into a sample collection bag. The breath samples will be extracted and measured using the Quintron Breath Track Analyzer. This will be a marker of carbohydrate fermentation in the colon.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breath hydrogen response</measure>
    <time_frame>60 minutes</time_frame>
    <description>At 60 minutes, subjects will be asked to exhale a full breath into a sample collection bag. The breath samples will be extracted and measured using the Quintron Breath Track Analyzer. This will be a marker of carbohydrate fermentation in the colon.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breath hydrogen response</measure>
    <time_frame>120 minutes</time_frame>
    <description>At 120 minutes, subjects will be asked to exhale a full breath into a sample collection bag. The breath samples will be extracted and measured using the Quintron Breath Track Analyzer. This will be a marker of carbohydrate fermentation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Breath hydrogen response</measure>
    <time_frame>240 minutes</time_frame>
    <description>At 240 minutes, subjects will be asked to exhale a full breath into a sample collection bag. The breath samples will be extracted and measured using the Quintron Breath Track Analyzer. This will be a marker of carbohydrate fermentation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal tolerance</measure>
    <time_frame>48 hours</time_frame>
    <description>Subjects will answer a 7 symptom questionnaire regarding the intensity of gastrointestinal symptoms experienced following consumption of each of the supplements. Questionnaire is adapted from the validated Bovenshen gastrointestinal tolerance questionnaire. Questionnaire is to be completed at baseline, 30 min, 60 min, 90 min, 120 min, 180 min, 12 hours, 24 and 48 hours.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Food Selection</condition>
  <arm_group>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low FODMAP Oral Nutrition Supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low FODMAP Oral Nutrition Supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low FODMAP Oral Nutrition Supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FOS Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supplement containing fructooligosaccharides</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low FODMAP Oral Nutrition Supplement</intervention_name>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 1</arm_group_label>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 2</arm_group_label>
    <arm_group_label>Low FODMAP Oral Nutrition Supplement 3</arm_group_label>
    <arm_group_label>FOS Supplement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between the ages of 18-65 years with a body mass index between 18-29 kg/m2.

          -  Demonstrates spoken and written English literacy and able to provide written, informed
             consent after review of study protocol and procedures.

        Exclusion Criteria:

          -  Use of enemas, proton pump inhibitors, or antibiotics within the past 3 months

          -  Smoker

          -  Not a regular breakfast eater

          -  Self-reported history of a past or current gastrointestinal disease

          -  High fiber eater (&gt; or = to 3 servings of high fiber foods per day)

          -  Concurrent or recent (within 30 days) participation in an intervention trial

          -  Recent weight fluctuations

          -  Allergies to any of the test products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Slavin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2016</study_first_submitted>
  <study_first_submitted_qc>January 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

